Maximiliano Jimenez-Dalmaroni

960 total citations
9 papers, 684 citations indexed

About

Maximiliano Jimenez-Dalmaroni is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Maximiliano Jimenez-Dalmaroni has authored 9 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Maximiliano Jimenez-Dalmaroni's work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (3 papers). Maximiliano Jimenez-Dalmaroni is often cited by papers focused on Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (3 papers). Maximiliano Jimenez-Dalmaroni collaborates with scholars based in United States, United Kingdom and New Zealand. Maximiliano Jimenez-Dalmaroni's co-authors include Iannis E. Adamopoulos, Marina Franceschetti, Abbas Maqbool, Sophien Kamoun, Helen G. Pennington, Mark J. Banfield, Pedro R. Löwenstein, María G. Castro, Jinwei Hu and Anne David and has published in prestigious journals such as PLoS ONE, Microbiology and Molecular Biology Reviews and Developmental Biology.

In The Last Decade

Maximiliano Jimenez-Dalmaroni

9 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximiliano Jimenez-Dalmaroni United States 8 254 244 132 91 85 9 684
Paula Kuo Taiwan 17 283 1.1× 286 1.2× 117 0.9× 87 1.0× 121 1.4× 38 767
L. Black United States 16 169 0.7× 109 0.4× 115 0.9× 58 0.6× 79 0.9× 43 763
Arun Subramaniam United States 14 467 1.8× 256 1.0× 50 0.4× 60 0.7× 80 0.9× 27 1.0k
Yingyos Jittayasothorn United States 14 355 1.4× 439 1.8× 208 1.6× 98 1.1× 185 2.2× 31 1.2k
Gen Takahashi Japan 14 270 1.1× 283 1.2× 37 0.3× 83 0.9× 83 1.0× 36 855
Dominik Filipp Czechia 18 316 1.2× 441 1.8× 54 0.4× 99 1.1× 39 0.5× 43 886
Yuya NAKAMOTO Japan 14 177 0.7× 270 1.1× 157 1.2× 146 1.6× 46 0.5× 49 842
Arwen L. Hunter Canada 10 463 1.8× 146 0.6× 64 0.5× 95 1.0× 182 2.1× 12 904
Zhijie Lin China 19 387 1.5× 172 0.7× 103 0.8× 50 0.5× 187 2.2× 49 886
Susan D’Costa United States 18 319 1.3× 129 0.5× 130 1.0× 231 2.5× 69 0.8× 41 746

Countries citing papers authored by Maximiliano Jimenez-Dalmaroni

Since Specialization
Citations

This map shows the geographic impact of Maximiliano Jimenez-Dalmaroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximiliano Jimenez-Dalmaroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximiliano Jimenez-Dalmaroni more than expected).

Fields of papers citing papers by Maximiliano Jimenez-Dalmaroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximiliano Jimenez-Dalmaroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximiliano Jimenez-Dalmaroni. The network helps show where Maximiliano Jimenez-Dalmaroni may publish in the future.

Co-authorship network of co-authors of Maximiliano Jimenez-Dalmaroni

This figure shows the co-authorship network connecting the top 25 collaborators of Maximiliano Jimenez-Dalmaroni. A scholar is included among the top collaborators of Maximiliano Jimenez-Dalmaroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximiliano Jimenez-Dalmaroni. Maximiliano Jimenez-Dalmaroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Caldwell, Julie M., Margaret H. Collins, Katherine A. Kemme, et al.. (2017). Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation. Mucosal Immunology. 10(5). 1190–1201. 37 indexed citations
2.
Franceschetti, Marina, Abbas Maqbool, Maximiliano Jimenez-Dalmaroni, et al.. (2017). Effectors of Filamentous Plant Pathogens: Commonalities amid Diversity. Microbiology and Molecular Biology Reviews. 81(2). 136 indexed citations
3.
Jimenez-Dalmaroni, Maximiliano, et al.. (2015). The critical role of toll-like receptors — From microbial recognition to autoimmunity: A comprehensive review. Autoimmunity Reviews. 15(1). 1–8. 207 indexed citations
4.
Jimenez-Dalmaroni, Maximiliano, Catherine M. Radcliffe, David J. Harvey, et al.. (2014). Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids. Innate Immunity. 21(2). 175–193. 17 indexed citations
5.
Jimenez-Dalmaroni, Maximiliano, et al.. (2011). Control of cortical actin assembly and cadherin-catenin localization by RhoGTPases. Developmental Biology. 356(1). 137–137. 1 indexed citations
6.
Jimenez-Dalmaroni, Maximiliano, Nengming Xiao, Adam L. Corper, et al.. (2009). Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2. PLoS ONE. 4(10). e7411–e7411. 78 indexed citations
7.
Barcia, Carlos, Maximiliano Jimenez-Dalmaroni, Kurt M. Kroeger, et al.. (2007). One-year Expression From High-capacity Adenoviral Vectors in the Brains of Animals With Pre-existing Anti-adenoviral Immunity: Clinical Implications. Molecular Therapy. 15(12). 2154–2163. 64 indexed citations
8.
Löwenstein, Pedro R., et al.. (2003). Virus Vectors for use in the Central Nervous System. International review of neurobiology. 55. 3–64. 7 indexed citations
9.
Castro, María G., R. Cowen, Ian Williamson, et al.. (2003). Current and future strategies for the treatment of malignant brain tumors. Pharmacology & Therapeutics. 98(1). 71–108. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Kuo Breakdown of academic impact, for papers by L. Black Breakdown of academic impact, for papers by Arun Subramaniam Breakdown of academic impact, for papers by Yingyos Jittayasothorn Breakdown of academic impact, for papers by Gen Takahashi Breakdown of academic impact, for papers by Dominik Filipp Breakdown of academic impact, for papers by Yuya NAKAMOTO Breakdown of academic impact, for papers by Arwen L. Hunter Breakdown of academic impact, for papers by Zhijie Lin Breakdown of academic impact, for papers by Susan D’Costa
Rankless by CCL
2026